Autoimmune Diseases: all 672 studies
Page 3 of 7. Open to participants first (272), then studies with results posted, then the rest; newest registration first within each.
- Study of Dengue in Patients With Autoimmune Diseases During the Epidemics of 2020 and 2021 in Reunion IslandNot yet recruitingNCT05852977
- An Observational Study of Patients With Autoimmune DiseaseNot yet recruitingNCT05842824
- Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MSRecruitingNCT05834855Phase 3
- AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple SclerosisRecruitingNCT05832515Phase 1
- Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in ChinaRecruitingNCT05831826
- Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementRecruitingNCT05789030Not applicable
- Treatment Strategies for IgG4-RD Patients With Internal Organ InvolvementRecruitingNCT05789017Not applicable
- Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in ChinaRecruitingNCT05726461Not applicable
- Modelling and Control of Non-invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A)RecruitingNCT05704153Not applicable
- Daratumumab in Primary Antiphospholipid SyndromeRecruitingNCT05671757Phase 1/2
- Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic DiseasesRecruitingNCT05670301Not applicable
- Allergy and Immunology Natural History StudyRecruitingNCT05584488
- CAR-T Cells Targeting Autoimmune DiseasesNot yet recruitingNCT05459870Phase 1/2
- Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)RecruitingNCT05418010Phase 2
- Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune DiseasesEnrolling by invitationNCT05400954
- Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)RecruitingNCT05394922
- Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory DiseasesRecruitingNCT05383339
- The Pathogenesis of Depression - Possible Autoimmune MechanismsRecruitingNCT05293899
- Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune GastritisEnrolling by invitationNCT05238181
- Predictors and Prognostic Factors of Myasthenia Gravis OutcomeRecruitingNCT05214612
- MS-ResearchBiomarkerSRecruitingNCT05204459
- Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.RecruitingNCT05168215
- China National Registry of Neuro-Inflammatory DiseasesRecruitingNCT05154370
- BeAT1D: Benign Autoimmunity and Type 1 DiabetesRecruitingNCT05139784
- Montreal Immune-Related Adverse Events (MIRAE) StudyRecruitingNCT05139706
- Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite StudiesEnrolling by invitationNCT05041309
- A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) SyndromeRecruitingNCT05027945Phase 2
- ILD-SARDs Registry and BiorepositoryRecruitingNCT05007340
- Study of STIM1 Membrane ExpressionRecruitingNCT04978948
- tDCS in Post-Acute COVID-19 Patients With SARDsRecruitingNCT04890483Not applicable
- Prospective Study of White Blood CellsRecruitingNCT04838171
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruitingNCT04806620
- Biologics And Clinical Immunology Cohort at SinaiRecruitingNCT04784364
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruitingNCT04751396
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute ConditionsRecruitingNCT04684602Phase 1/2
- A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A NephropathyRecruitingNCT04663204Phase 2
- Secukinumab Open Label Roll-over Extension ProtocolRecruitingNCT04638647Phase 4
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemRecruitingNCT04561557Early Phase 1
- Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic ManagementRecruitingNCT04521790
- Abatacept for the Treatment of Giant Cell ArteritisRecruitingNCT04474847Phase 3
- Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue GraftingRecruitingNCT04452305Not applicable
- A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)RecruitingNCT04422912Phase 1/2
- Study of Pathophysiology of Status Epilepticus and Dysimmune EncephalitisRecruitingNCT04421846Not applicable
- A Registered Cohort Study of Inflammatory Demyelination DiseaseRecruitingNCT04386018
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of ImmunityRecruitingNCT04339777Phase 2
- Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)RecruitingNCT04304820Phase 2Results posted
- Antibiotic Prophylaxis in High-Risk Arthroplasty PatientsEnrolling by invitationNCT04297592Phase 4
- Autoimmunity After Checkpoint BlockadeRecruitingNCT04119713
- Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)RecruitingNCT04097561Phase 1
- Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune EncephalitisRecruitingNCT03993262Phase 2
- VNS Prospective Neuromodulation of Immune and Gastrointestinal SystemsRecruitingNCT03953768Not applicable
- Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical ConditionsNot yet recruitingNCT03899298Phase 1
- Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective StudyNot yet recruitingNCT03870828
- Collection and Distribution of Biospecimens for Novel Research UsesRecruitingNCT03848962
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
- Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem CellsRecruitingNCT03673748Phase 2
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruitingNCT03276923
- NIAID Centralized Sequencing ProtocolRecruitingNCT03206099
- Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease ActivityRecruitingNCT03003572
- Testicular Tissue Cryopreservation for Fertility PreservationRecruitingNCT02972801Not applicable
- Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary ImmunodeficienciesRecruitingNCT02579967Phase 2
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling by invitationNCT02422875
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruitingNCT02103361
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)RecruitingNCT01351545
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingRecruitingNCT01280825
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruitingNCT01276470
- Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRecruitingNCT00977977Phase 2
- Natural History of BronchiectasisRecruitingNCT00943514
- Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ LymphocytopeniaRecruitingNCT00867269
- Serum Auto-Antibodies in Neurological DiseasesEnrolling by invitationNCT00704626
- Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell DeathRecruitingNCT00246857
- Study of Autoimmune Lymphoproliferative Syndrome (ALPS)RecruitingNCT00001350
- Defining Stress REsilience And Mindfulness Effects in Rheumatoid ArthritisCompletedNCT06276387Not applicableResults posted
- Epidural Stimulation in Multiple SclerosisCompletedNCT06019611Not applicableResults posted
- A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisTerminatedNCT05516758Phase 2Results posted
- A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral DosesCompletedNCT05218434Phase 1Results posted
- Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) AntibodiesCompletedNCT05148806Results posted
- COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
- ALPN-101 (Acazicolcept) in Systemic Lupus ErythematosusCompletedNCT04835441Phase 2Results posted
- A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy SubjectsCompletedNCT04818229Phase 1Results posted
- Safety and Efficacy Study of VIS649 for IgA NephropathyCompletedNCT04287985Phase 2Results posted
- Tofacitinib for Immune Skin Conditions in Down SyndromeCompletedNCT04246372Phase 2Results posted
- Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid ArthritisCompletedNCT04186871Phase 2Results posted
- Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis PatientsCompletedNCT04071405Results posted
- Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDASTerminatedNCT04015596Phase 4Results posted
- Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025CompletedNCT03907540Phase 1Results posted
- Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's SyndromeCompletedNCT03905525Phase 2Results posted
- Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or DysregulationActive, not recruitingNCT03663933Phase 2Results posted
- A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772CompletedNCT03649412Phase 1Results posted
- Phase I Study of GSK2982772 in Japanese Healthy Male ParticipantsCompletedNCT03590613Phase 1Results posted
- Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With OcrevusCompletedNCT03562975Results posted
- Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy VolunteersCompletedNCT03530995Phase 1Results posted
- Disease-Modifying Treatments for Myasthenia GravisCompletedNCT03490539Results posted
- Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar ProteinosisTerminatedNCT03482752Phase 3Results posted
- Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 DiabetesCompletedNCT03345004Phase 2Results posted
- A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy SubjectsCompletedNCT03305419Phase 1Results posted
- A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat DosesCompletedNCT03266172Phase 1Results posted
- Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 DiabetesCompletedNCT03199638Not applicableResults posted
- Aerobic Exercise in Women With Systemic Lupus ErythematosusTerminatedNCT03186794Not applicableResults posted
- Fecal Microbial Transplantation in Relapsing Multiple Sclerosis PatientsTerminatedNCT03183869Phase 2Results posted